State-level insulin cost caps ineffective in increasing insulin use among diabetes patients

FHS
August 5, 2024
11:29 am

In a first-of-its-kind study, a cohort of researchers, led by the University of Colorado Anschutz Medical Campus, evaluated the effects of state-level insulin out-of-pocket costs across states and payers and over time.

Intellia, Verve run clinical trials abroad amid FDA’s ‘cautious’ approach to gene editing

Intellia Therapeutics announced earlier this month that it would run a mid-stage trial of a CRISPR-based treatment for a rare genetic disease called hereditary angioedema

August 18, 2023

FDA Forms Digital Health Advisory Committee

What You Should Know: – The U.S. Food and Drug Administration (FDA) has formed a new Digital Health Advisory Committee to help the agency explore

October 14, 2023

Study Raises Questions About Key Features of H5N1 Infection in Cattle

A new paper challenged two ideas about how the H5N1 bird flu behaves in cattle: that it always produces mild illness, and that asymptomatic animals

July 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.